<DOC>
	<DOCNO>NCT01366040</DOCNO>
	<brief_summary>This open-label , multicenter , survey-based study determine subject satisfaction use single-use autoinjector delivery AVONEX PS . Enrollment consist 200 subject single cohort prescribe AVONEX PEN accord Product Monograph . All subject must experience AVONEX PS user ( i.e. , use least 12 week without support person help injection administer vastus lateralis ) enrol MS AllianceTM program ( hereinafter , MS Alliance ) . The clinic nurse investigator instruct patient correct method use AVONEX PEN first injection Autoinjector , use subject 's supply , complete clinic , clinic nurse investigator present . All injection AVONEX PEN self-administered home . The subject complete first set questionnaire , include Subject Satisfaction Questionnaire , Ease Use Grading Scale Autoinjector Instructions Grading Scale , within 10 minute first injection clinic , give another set questionnaires complete home within 10 minute follow last study injection 2 month later , provide subject still continue self-administer AVONEX PEN . The first set questionnaire leave clinic nurse investigator send CRO fax e-mail , second set need mail CRO study subject use provide self-addressed , postage-paid envelope .</brief_summary>
	<brief_title>Avonex PEN Satisfaction Patients Experience Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Must give write informed consent . If require local law , candidate must also authorize release use Protected Health Information ( PHI ) Must 18 65 year old , inclusive , time informed consent Must AVONEX PS least 12 consecutive week Must selfinjecting AVONEX PS vastus lateralis site without help , without use Personal Injector Must prescribe AVONEX PEN per local labeling ( Product Monograph ) enrol MS Alliance Must able physically demonstrate use Autoinjector device able selfadminister injection Must able understand comply protocol Female subject consider become pregnant study currently pregnant breastfeed Other unspecified reason , opinion Investigator Sponsor , make subject unsuitable enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Patient Satisfaction</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Autoinjector</keyword>
	<keyword>Avonex</keyword>
</DOC>